WWOX - The FRA16D cancer gene: Expression correlation with breast cancer progression and prognosis

European Journal of Surgical Oncology

Volumn 32, Issue 2, 2006, Pages 153-157

  Pluciennik E ^a   Kusinska R ^a   Potemski, P ^a   Kubiak, R ^a   Kordek, R ^a   Bednarek, A K ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Breast cancer; Tumour suppressor gene

Indexed keywords

CYTOKERATIN 17; CYTOKERATIN 5; CYTOKERATIN 6; ESTROGEN RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN WWOX; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER GROWTH; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME FRAGILE SITE; CONTROLLED STUDY; CORRELATION ANALYSIS; ESTROGEN METABOLISM; FEMALE; GENE TARGETING; GENE THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WILD TYPE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; APOPTOSIS; BREAST NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ESTROGEN RECEPTOR ALPHA; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; OXIDOREDUCTASES; POLAND; PROGNOSIS; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 32944460958     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2005.11.002     Document Type: Article

References (30)

1. A.K. Bednarek K.J. Laflin R.L. Daniel Q. Liao K.A. Hawkins C.M. Aldaz WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer Cancer Res 60 8 2000 2140-2145
2. J.H. Ludes-Meyers A.K. Bednarek N.C. Popescu M. Bedford C.M. Aldaz WWOX, the common chromosomal fragile site, FRA16D, cancer gene Cytogenet Genome Res 100 1-4 2003 101-110
3. A. Matsuyama C.M. Croce K. Huebner Common fragile genes Eur J Histochem 48 1 2004 29-36
4. T. Chen A. Sahin C.M. Aldaz Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: Refining a putative tumor suppressor gene region Cancer Res 56 24 1996 5605-5609
5. K. Driouch H. Prydz R. Monese H. Johansen R. Lidereau E. Frengen Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors Oncogene 21 12 2002 1832-1840
6. G. Guler A. Uner N. Guler S.Y. Han D. Iliopoulos W.W. Hauck The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma Cancer 100 8 2004 1605-1614
7. M.I. Nunez J. Ludes-Meyers M.C. Abba H. Kil N.W. Abbey R.E. Page Frequent loss of WWOX expression in breast cancer: Correlation with estrogen receptor status Breast Cancer Res Treat 89 2 2005 99-105
8. G. Guler A. Uner N. Guler S.Y. Han D. Iliopoulos P. McCue Concordant loss of fragile gene expression early in breast cancer development Pathol Int 55 8 2005 471-478
9. A.J. Paige K.J. Taylor C. Taylor S.G. Hillier S. Farrington D. Scott WWOX: A candidate tumor suppressor gene involved in multiple tumor types Proc Natl Acad Sci USA 98 20 2001 11417-11422
10. C. Gourley A.J. Paige K.J. Taylor D. Scott N.J. Francis R. Rush WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear Int J Oncol 26 6 2005 1681-1689
11. M.I. Nunez D.G. Rosen J.H. Ludes-Meyers M.C. Abba H. Kil R. Page WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome BMC Cancer 5 1 2005 64
12. S.W. Park J. Ludes-Meyers D.B. Zimonjic M.E. Durkin N.C. Popescu C.M. Aldaz Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma Br J Cancer 91 4 2004 753-759
13. R.I. Aqeilan T. Kuroki Y. Pekarsky O. Albagha F. Trapasso R. Baffa Loss of WWOX expression in gastric carcinoma Clin Cancer Res 10 9 2004 3053-3058
14. T. Kuroki S. Yendamuri F. Trapasso A. Matsuyama R.I. Aqeilan H. Alder The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis Clin Cancer Res 10 7 2004 2459-2465
15. T. Kuroki F. Trapasso T. Shiraishi H. Alder K. Mimori M. Mori Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma Cancer Res 62 8 2002 2258-2260
16. S. Yendamuri T. Kuroki F. Trapasso A.C. Henry K.R. Dumon K. Huebner WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer Cancer Res 63 4 2003 878-881
17. H. Ishii A. Vecchione Y. Furukawa K. Sutheesophon S.Y. Han T. Druck Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies Mol Cancer Res 1 13 2003 940-947
18. D. Iliopoulos G. Guler S.Y. Han D. Johnston T. Druck K.A. McCorkell Fragile genes as biomarkers: Epigenetic control of WWOX and FHIT in lung, breast and bladder cancer Oncogene 2005
19. A. Watanabe Y. Hippo H. Taniguchi H. Iwanari M. Yashiro K. Hirakawa An opposing view on WWOX protein function as a tumor suppressor Cancer Res 63 24 2003 8629-8633
20. A.K. Bednarek C.L. Keck-Waggoner R.L. Daniel K.J. Laflin P.L. Bergsagel K. Kiguchi WWOX, the FRA16D gene, behaves as a suppressor of tumor growth Cancer Res 61 22 2001 8068-8073
21. M. Mitas K. Mikhitarian C. Walters P.L. Baron B.M. Elliott T.E. Brothers Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel Int J Cancer 93 2 2001 162-171
22. K.J. Livak T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 4 2001 402-408
23. W.L. Duax D. Ghosh Structure and function of steroid dehydrogenases involved in hypertension, fertility, and cancer Steroids 62 1997 95-100
24. Y. Kallberg U. Oppermann H. Jornvall B. Persson Short-chain dehydrogenase/reductase (SDR) relationships: A large family with eight clusters common to human, animal, and plant genomes Protein Sci 11 3 2002 636-641
25. Z. Marijanovic D. Laubner G. Moller C. Gege B. Husen J. Adamski Closing the gap: Identification of human 3-ketosteroid reductase, the last unknown enzyme of mammalian cholesterol biosynthesis Mol Endocrinol 17 9 2003 1715-1725
26. N.S. Chang L. Schultz L.J. Hsu J. Lewis M. Su C.I. Sze 17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo Oncogene 24 4 2005 714-723
27. S. Veronese F.A. Mauri O. Caffo M. Scaioli D. Aldovini G. Perrone Bax immunohistochemical expression in breast carcinoma: A study with long term follow-up Int J Cancer 79 1 1998 13-18
28. M. Vakkala K. Lahteenmaki H. Raunio P. Paakko Y. Soini Apoptosis during breast carcinoma progression Clin Cancer Res 5 2 1999 319-324
29. Q. Yang T. Sakurai X. Jing H. Utsunomiya L. Shan Y. Nakamura Expression of Bcl-2, but not Bax, correlates with estrogen receptor status and tumor proliferation in invasive breast carcinoma Pathol Int 49 9 1999 775-780
30. T. Sorlie C.M. Perou R. Tibshirani T. Aas S. Geisler H. Johnsen Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 19 2001 10869-10874